S Ichikawa

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. Ichikawa S, Austin A, Gray A, Allen M, Econs M. Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis. Endocrinology. 2011;152:4504-13 pubmed publisher
    ..In conclusion, dietary phosphate restriction normalizes biochemical and skeletal phenotypes of Galnt3 knockout mice and, thus, can be an effective therapy for tumoral calcinosis. ..
  2. Ichikawa S, Baujat G, Seyahi A, Garoufali A, Imel E, Padgett L, et al. Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations. Am J Med Genet A. 2010;152A:896-903 pubmed publisher
    ..Therefore, tumoral calcinosis and hyperostosis-hyperphosphatemia syndrome represent a continuous spectrum of the same disease caused by increased phosphate levels, rather than two distinct disorders. ..
  3. Ichikawa S, Austin A, Gray A, Econs M. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells. J Bone Miner Res. 2012;27:453-60 pubmed publisher
    ..These data suggest that Phex mutations alter the responsiveness of bone cells to extracellular phosphate concentrations and may create a lower set point for "normal" phosphate levels. ..